v3.24.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Federal grants $ 3,418,853 $ 435,380 $ 3,906,372 $ 1,715,488
Operating expenses:        
Research and development 1,690,674 1,914,970 3,416,807 5,354,713
General and administrative 1,083,433 1,227,724 3,643,223 3,923,277
Total operating expenses 2,774,107 3,142,694 7,060,030 9,277,990
Income (loss) from operations 644,746 (2,707,314) (3,153,658) (7,562,502)
Other income (expense):        
Change in fair value of convertible notes 146,479
Change in fair value of liability classified warrants 6,403 17,223 23,175 279,873
Interest expense, net (4,063) (7,649) (1,279,691) (9,146)
Other income (expense), net 14,683 6,934 (12,413) 23,382
Total other income (expense), net 17,023 16,508 (1,268,929) 440,588
Net income (loss) 661,769 (2,690,806) (4,422,587) (7,121,914)
Net loss attributable to noncontrolling interests (1,235) (74) (12,236)
Deemed dividend related to warrants down round provision 290 12,038
Net income (loss) attributable to common stockholders $ 661,769 $ (2,689,571) $ (4,422,803) $ (7,121,716)
Net income (loss) per basic and diluted share:        
Net income (loss) per share attributable to common stockholders, basic $ 0.07 $ (0.87) $ (0.57) $ (3.32)
Net income (loss) per share attributable to common stockholders, diluted $ 0.07 $ (0.87) $ (0.57) $ (3.32)
Weighted average common shares outstanding, basic 9,890,390 3,085,873 7,782,540 2,145,505
Weighted average common shares outstanding, diluted 9,890,390 3,085,873 7,782,540 2,145,505

Source